Skip to main content
Clinical Trials/CTRI/2018/01/011373
CTRI/2018/01/011373
Not yet recruiting
未知

A randomized controlled trial comparing the efficacy and safety profile of oral versus subcutaneous route of methotrexate administration in moderate to severe psoriasis - METOS

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Psoriasis Vulgaris
Sponsor
Postgraduate Institute of Medical Education and Research
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\)Patients aged more than 18 years with clinical diagnosis of plaque psoriasis
  • 2\)Patients with body surface area involvement \> 10 %, PASI \>10,

Exclusion Criteria

  • 1\)Hemoglobin \< 8 gm/dl ,Total leukocyte count \< 3500/ mm3, Platelet count \< 100,000/mm3
  • 2\)Elevation of hepatic enzymes (alanine aminotransferase \[ALT], aspartate aminotransferase \[AST], or γ glutamyl transferase \[GGT]) to more than twice the upper limit of normal.
  • 3\)Hepatitis, active or recurrent, cirrhosis or excessive current alcohol intake .
  • 4\)Use of other hepatotoxic drugs by the patient
  • 5\)Positive hepatitis B, hepatitis C or HIV serology
  • 6\)Pulmonary or extra\-pulmonary active tuberculosis
  • 7\)Deranged renal function test.
  • 8\)Pregnancy or lactation or if patient is planning to conceive during the treatment period.
  • 9\)Patient on other immunosuppressive drugs
  • 10\)Recent live vaccination

Outcomes

Primary Outcomes

Not specified

Similar Trials